Read More Pharma Industry News Dizal’s sunvozertinib shows promising results in global pivotal lung cancer study Dizal, a prominent biopharmaceutical company listed on the Shanghai Stock Exchange (SSE:688192), has announced significant clinical results from… byPallavi MadhirajuJune 2, 2024